Evidence map›Paper›PMID 41413908›Full record

ArticleSystematic reviews2025

Accelerating the pace and accuracy of systematic reviews using AI: a validation study.

Jiada Zhan, Kara Suvada, Muwu Xu, Wenya Tian, Kelly C Cara, Taylor C Wallace, Mohammed K Ali

Abstract readValidation Study
In one paragraph

Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiada Zhan *Nutrition and Health Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA. jzha832@emory.edu.ORCID 0000-0003-2480-8760
Kara Suvada *Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. ksuvada@emory.edu.
Muwu XuDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.
Wenya TianWuXi AppTec, San Diego, CA, USA.
Kelly C CaraPopulation Science, American Cancer Society, Atlanta, GA, USA.
Taylor C WallacePopulation Science, American Cancer Society, Atlanta, GA, USA.
Mohammed K AliDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) can greatly enhance efficiency in systematic literature reviews and meta-analyses, but its accuracy in screening titles/abstracts and full-text articles is uncertain.

objectivesThis study evaluated the performance metrics (sensitivity, specificity) of a GPT-4 AI program, Review Copilot, against human decisions (gold standard) in screening titles/abstracts and full-text articles from four published systematic reviews/meta-analyses. RESEARCH

designParticipant data from four already-published systematic literature reviews were used for this validation study. This was a study comparing Review Copilot to human decision-making (gold standard) in screening titles/abstracts and full-text articles for systematic reviews/meta-analyses. The four studies that were used in this study included observational studies and randomized control trials. Review Copilot operates on the OpenAI, GPT-4 server. We examined the performance metrics of Review Copilot to include and exclude titles/abstracts and full-text articles as compared to human decisions in four systematic reviews/meta-analyses. Sensitivity, specificity, and balanced accuracy of title/abstract and full-text screening were compared between Review Copilot and human decisions.

resultsReview Copilot's sensitivity and specificity for title/abstract screening were 99.2% and 83.6%, respectively, and 97.6% and 47.4% for full-text screening. The average agreement between two runs was 95.4%, with a kappa statistic of 0.83. Review Copilot screened in one-quarter of the time compared to humans.

conclusionsAI use in systematic reviews and meta-analyses is inevitable. Health researchers must understand these technologies' strengths and limitations to ethically leverage them for research efficiency and evidence-based decision-making in health.

Indexed as

Artificial IntelligenceSystematic Reviews as TopicDecision MakingHumansMeta-Analysis as TopicSensitivity and Specificity

Identifiers

PMID41413908
PMCPMC12829171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.